公司资料
Clarus Therapeutics 股价、新闻与催化剂
- 股票代码:
- CRXT
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股价为何变动
Current closing-price context is not available for CRXT.
公司概览
业务概览
Clarus Therapeutics was a specialty pharmaceutical company focused on testosterone replacement and men’s health before becoming a historical ticker. Its business centered on hormone therapy and specialty commercialization.
所在地与行业分类
Clarus Therapeutics was headquartered in the United States and listed on NASDAQ. It sat in specialty pharma and men’s health.
商业模式特征
The company depended on product commercialization, market access, and the ability to build a sustainable specialty franchise. Investors historically watched revenue, reimbursement, and strategic financing or restructuring.
生物医药行业定位
Clarus belongs in the historical specialty-pharma bucket. Its stock was driven more by commercial execution and capital structure than by classic biotech catalysts.
未来催化剂
- Clarus Therapeutics is now largely a legacy / closeout story, with catalysts limited to any asset or corporate-resolution update. There is no broad live pipeline story left.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。